TPG Growth bets on Indian mid-sized bulk drugs firm

By Joseph Rai

  • 01 Feb 2019
Premium

TPG Growth, the mid-market and growth equity platform of private equity firm TPG, has bet on a bulk-drugs company in the investment group’s second deal in the pharmaceutical sector within six months. TPG Growth is infusing Rs 200 crore ($28 million) into Solara Active Pharma Sciences Ltd. It would pick up ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Already a member? Click here to log in.